Profil
Andreas Maetzel served as Vice President-Global Medical Affairs at BioCryst Pharmaceuticals, Inc. from 2014 to 2017.
Prior to that, he was VP-Clinical Development & Regulatory Affairs at Cornerstone Therapeutics, Inc. from 2013 to 2014.
He also worked as Senior Vice President-Medical at KalVista Pharmaceuticals, Inc. Dr. Maetzel holds a graduate and doctorate degree from the University of Toronto and a doctorate degree from the University of Hannover.
Anciens postes connus de Andreas Maetzel
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2017 |
| CORNERSTONE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2014 |
| KALVISTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Andreas Maetzel
| University of Toronto | Doctorate Degree |
| University of Hannover | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| KALVISTA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
